Therapeutic Interventions for Bacterial Infections Flashcards

1
Q

Structure of bacterial cell walls

A
  • peptidoglycan molecules in their cell walls that protect them from the environment
  • peptidoglycan molecules form a set of chains called penicillin-binding proteins because penicillins and related antibiotics bind to them
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Penicillins

A
  • beta-lactam ring structure of penicillin binds PBPs causing lysis of growing bacteria by damaging cell walls
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Resistance to penicillin

A
  • mutate so they lack the PBPs that are the target of penicillins
  • secrete an enzyme (penicillinase or beta-lactamase) that splits penicillin;s beta-lactam ring, often in response to penicillin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Penicillin Generalization

A
  • mainly active against gram-positive bacteria
  • most have narrow spectrum of antimicrobial activity
  • widely distributed to tissues
  • nearly all are rapidly excreted by kidneys
  • short half-lives so it has to be given more often
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Prototype Drug: Penicillin G Potassium

  1. therapeutic effects and uses
  2. mechanism of action
  3. Adverse effects
A
  1. mostly gram-positive bacteria/ bacterial endocarditis and prosthetic heart valves, rheumatic fever, congenital heart disease
    2/ inhibits bacteral cell wall synthesis by binding to PBPs
  2. urticaria/allergies/anaphylaxis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cephalosporins - 20 types in 5 generations

A
  • first - gram positive and some gram negative
  • second - broader spectrum than first
  • third - broader spectrum than second and longer duration of action
  • fourth - effective against bacteria that are resistant to earlier generations
  • fifth - extended gram-positive effectiveness, including MRSA infections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cephalosporins Generalizations

A
  • generally safe
  • most common side effects (allergy/rash/GI complaints)
  • elimination in kidneys
  • use with caution in nursing mothers and patients with renal impairment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cephalosporin prototype Drug: Cefotaxime

  1. therapeutic effects and uses
  2. mechanism of action
  3. adverse effects
A

1 . third generation cephalosporin with broad spectrum activity against both gram + and gram - / infections of the respiratory tract, urinary tract, genital infections, septicemia, meningitis, endocarditis, bone and joint infections
/infection prophylaxis in surgical patients
2. inhibits bacterial wall synthesis by binding to specific PBPs
3. rash, diarrhea, allergic response, potential superinfection, pain, phlebitis and IM injection sites, anaphylaxis, seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Carbapenems

A

broad-spectrum antibiotics with similar properties to other beta-lactams

  • provide better activity against serious gram - and multidrug resistant infections than most cephalosporins or penicillins
  • low incidence of adverse effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Tetracyclines

A
  • active against both gram negative and gram positive bacterial.
  • drug of choice for typhus, cholera, rocky mountain spotted fever, lyme disease, H. pylori, ulcers and chlamydia
  • bacteriostatic - prevents formation of proteins from amino acids. prevents making of bacterial cell wall.
  • wide spread resistant to tetracycline has developed.
  • take on empty stomach
  • incompletely absorbed in intestine, thus can alter flora, causes super-infection
  • if given parenterally, can be hepatotoxic and cause photosensitivity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Prototype Drug Tetracycline

  1. therapeutic effects and uses
  2. mechanism of action
  3. Adverse effects
  4. Serious Adverse effects
A
  1. susceptible gram + and gram - bacterial including: chlamydia, rickettsia, mycoplasmas, certain protozoa, H. pylori
  2. inhibits bacterial protein synthesis. Terminates the growing amino acid chain prematurely
  3. super infections/nausea vomiting epigastric burning diarrhea/discoloration of teeth/photosensitivity/
  4. hepatotoxicity/anaphylaxis/exfoliative dermatitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Macrolides

A
  • most effective against gram-positive
  • alternative drugs for patients allergic to penicillin
  • generally well tolerated and safe
  • decreased hepatic metabolism of other drugs thus drug interactions are possible
  • bacteriostatic in low doses, can be bactericidal in high doses
  • suffix - thromycin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Macrolide prototype drug: Erythromycin

  1. therapeutic effect
  2. mechanism of action
  3. adverse effects
  4. serious adverse effects
A
  1. prophylaxis and treatment of susceptible bacterial infections including legionella, chlamydia, listeria, campylobacter, as well as upper and lower respiratory tract infections and skin infections
  2. inhibits protein synthesis/kills of bacteria/considered bacteriostatic, but may be bactericidal in high doses
  3. N&V/abdominal cramping/phlebitis
  4. Cholestatic hepatitis/ototoxicity (hearing loss, vertigo, dizziness)/cardiotoxicity - palpitations, chest pain, arrhythmias
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Aminoglycosides

A
  • effective against aerobic gram-negative bacteria including pseudomonas, enterobacteriaceae family, also used for TB
  • prevention of protein synthesis
  • bacteriostatic
  • reserved for serious systemic infections, must be given parenterally
  • associated with post-anitbiotic effect (activity of drug continues even as serum levels drop)
  • may serious adverse effects including nephrotoxicity, ototoxicity, and neuromuscular blockade, thus these drugs are only used when other drugs are not effective
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Aminoglycosides: Prototype Drug - Gentamicin

  1. therapeutic effects and uses
  2. Mechanism of action
  3. adverse effects
  4. serious adverse effects
A
  1. serious infections caused by aerobic, gram-negative bacilli/a few gram-positive bacteria, including some strains of MRSA
  2. inhibits protein synthesis
  3. N&V/rash and fatigue
  4. ototoxicity/nephrotoxicity/neurmuscular blockage/neurotoxicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Fluoroquinolones

A
  • prevent DNA replication
  • four generations with activity on all gram-negative bacteria, with some activity on gram-positive bacteria
  • commonly used for urinary tract infections, GI, respiratory and skin infections
  • common suffix - floxacin
17
Q

Fluoroquinolones prototype drug: Ciprofloxacin

  1. therapeutic effects and uses
  2. mechanism of action
  3. Adverse effects
  4. serious adverse effects
A
  1. UTI/sinusitis/pneumonia/infectious diarrhea/certain eye infections/skin, bone and join infections
  2. prevents DNA replication
  3. N&V/diarrhea/phototoxicity/headache/tendonitis/dizziness
  4. pseudomembranous colitis/seizures/toxic psychosis
18
Q

sulfonamides

A
  • active against broad spectrum of microorganisms, classified based on absorption and excretion qualities
  • suppress DNA replication by inhibiting synthesis of folic acid is necessary for thymine metabolism
  • adverse effects include hypersensitivity reactions, blood abnormalities, nausea, vomiting, anorexia
  • some strains are resistant to sulfonamides
19
Q

Sulfonamides prototype drug - Trimethoprim-Sulfamethoxazole

  1. therapeutic effects and uses
  2. mechanism of action
  3. adverse effects
  4. serious adverse effects
A
  1. UTI prophylaxis and UTI/prophylaxis and treatment of p. carinii and shigella/acute episodes during chronic bronchitis
  2. inhibits DNA replication
  3. N&V/skin rash/pruritis/fever/photosensitivity
  4. anaphylaxis, allergic myocarditis, stevens-johnson syndrom epidermal necrolysis, agranulocytosis, aplastic anemia
20
Q

Vancomycin

  1. therapeutic effects and uses
  2. mechanism of action
  3. Adverse effects
  4. serious adverse effects
A
  1. severe gram-positive infections resistant to safer antibiotics/off-label uses for meningitis and antibiotic-induced pseudomembranous colitits
  2. inhibits synthesis of bacterial cell wall/increases permeability of bacterial cell membrane/alters RNA synthesis
  3. red man syndrom - red rash/ nausea, rash, fever, chills
  4. confusion/seizures/hallucinations/extravasation leading to tissue necrosis/ototoxicity/nephrotoxicity/anaphylaxis
21
Q

Common UTIs

A
  • urethritis, cystitis, prostatitis in males, pyelonephritis
22
Q

Common therapies for UTI

A

Sulfonamides
Fluroroquinolones
(drugs specific for UTIs are given b oral route and only reach effective concentrations in the kidneys)

23
Q

Prototype drug for UTI; Nitrofurantion

  1. therapeutic effects and uses
  2. mechanism of action
  3. side effects
  4. serious side effects
A
  1. Macrobid/macrodantin. uncomplicated acute cystitis, usually for prophylaxis of recurrent UTI.
  2. prevents protein synthesis, also inhibits cell wall synthesis
  3. hypersensitivity responses, nausea and vomiting, anorexia, headache, rash
  4. hepatotoxicity/acute and chronic pulmonary toxicity
24
Q

Tuberculosis

A

caused by mycobacterium tuberculosis, spread via airborne droplets, immune system response leads to formation of tubercles in lungs that surround mycobacteria

  • in healthy person - remain dormant and asymptomatic
  • if immunocompromised, infection becomes active
25
Q

Two major goals of pharmacological therapy of TB

A
  • eliminate all tubercle mycobacteria

- avoid emergence of resistant strains

26
Q

three differences of TB drug therapy compared to most bacterial infections

A
  1. therapy my last 6 to 12 months to allow agent to penetrate tubercles.
  2. multiple antibiotics are used to avoid resistance
  3. development of chemoprophylaxis is used to protect those at risk of infection
27
Q

Two phases of pharmacotherapy for Tb

A

initial phase - active cells are killed

continual phase - dormant mycobacteria are killed

28
Q

DOT

A

directly observed therapy

  • nurse must see patient swallow pill
  • necessary for high-risk patients that are non-compliant
29
Q

Prototype Drug for TB: Isoniazid

  1. therapeutic effects
  2. mechanism of action
  3. adverse effects
  4. serious adverse effects
A
  1. M. tuberculosis prophylaxis and treatment
  2. inhibits the synthesis of mycolic acid, a critical component of mycobacterial cell wall/bacteriocidal for rapidly dividing organisms/bacteriostatic for dormant mycobacteria
  3. rash/fever/numbness of hands and feet
  4. neurotoxicity(r/t decrease in vit B) /hepatotoxicity/blood dyscrasias